Evidence map›Paper›PMID 30979056›Full record

ArticleMolecules (Basel, Switzerland)2019

1,4-Naphthoquinone Analogues: Potent Antibacterial Agents and Mode of Action Evaluation.

Palanisamy Ravichandiran, Sunirmal Sheet, Dhanraj Premnath, Ae Rhan Kim, Dong Jin Yoo

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed.

  1. Fluorination of amino-quinones enhances anti-RSC medicinal chemistry · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Menadione as Antibiotic Adjuvant AgainstAntibiotics (Basel, Switzerland) · 2025
    Article
  9. Article
  10. Compound isolation through bioassay-guided fractionation of Tectona grandis leaf extract against Vibrio pathogens in shrimp.International microbiology : the official journal of the Spanish Society for Microbiology · 2024
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Palanisamy RavichandiranDepartment of Life Science, Department of Energy Storage/Conversion Engineering of Graduate School, and Hydrogen and Fuel Cell Research Center, Chonbuk National University, Jeollabuk-do 54896, Korea. ravichandru55@gmail.com.ORCID 0000-0001-5827-8230
Sunirmal SheetDepartment of Forest Science and Technology, College of Agriculture and Life Sciences, Chonbuk National University, 567 Baekje-daero, Deokjin-gu, Jeonju-si 561-756, Jeollabuk-do, Korea. sunirmal.micro@gmail.com.
Dhanraj PremnathDepartment of Biotechnology, Karunya Institute of Technology and Science, School of Agriculture and Biosciences, Karunya Nagar, Coimbatore 641114, Tamil Nadu, India. prems.bioinfo@gmail.com.
Ae Rhan KimR&D Center for CANUTECH, Business Incubation Center, Department of Bioenvironmental Chemistry, Chonbuk National University, Jeollabuk-do 54896, Korea. canutech@hanmail.net.
Dong Jin YooDepartment of Life Science, Department of Energy Storage/Conversion Engineering of Graduate School, and Hydrogen and Fuel Cell Research Center, Chonbuk National University, Jeollabuk-do 54896, Korea. djyoo@jbnu.ac.kr.ORCID 0000-0002-5707-3361

Funding

Korea Institute of Energy Technology Evaluation and Planning (KETEP) 20184030202210National Research Foundation of Korea NRF-2017R1A5A2015061
6 · The paper itself

Abstract

1,4-Naphthoquinones have antibacterial activity and are a promising new class of compound that can be used to treat bacterial infections. The goal was to improve effective antibacterial agents; therefore, we synthesized a new class of naphthoquinone hybrids, which contain phenylamino-phenylthio moieties as significant counterparts. Compound

Indexed as

Anti-Bacterial AgentsBacterial InfectionsEscherichia coliHumansKlebsiella pneumoniaeListeria monocytogenesMicrobial Sensitivity TestsNaphthoquinonesPseudomonas aeruginosaStaphylococcus aureus1,4-naphthoquinoneAnti-Bacterial AgentsNaphthoquinonesapoptosiskinetic studyquinonesROS generation

Identifiers

PMID30979056
PMCPMC6480589

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.